featured news
Free Weekly Newsletter.
We've been publishing our newsletter since 1998, and have had our share of huge winners including Immunomedics (IMMU) $3.00 to $86.00 (2016-2020). So sign up, it's free, and see what else we can come up with!
ALL NEWS
Cabaletta (CABA) Surges 44% on Massive Volume Spike.
Biotech 12 Pack Off to Nice Start..
Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April!
Biotech Stock Review is Back! 4 Companies Added to Watch List.
Cabaletta (CABA) Surges 44%...
GeoVax (GOVX) Surges 51% on Massive Volume Spike.
MonkeyPox and Gedeptin Related News Spark New Investor Interest.
MARKET BRIEF
On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated GeoVax report focusing on Monkey Pox, trading was light (195,000)....
Paving Past Obstacles on the Path to US Biosecurity
GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China.
National biosecurity has become a frequent topic of conversation in recent years as the US seeks to counter Chinese efforts...
Dinner Presentation With BioStem Technologies, Inc. (BSEM) in Boca Raton, FL
LIVE QUOTE
LONGER TERM CHART
Contact Ray Oliver at Bear Creek Capital for details.
RECENT NEWS
PRESENTATION
https://youtu.be/Au-pIqDHyto?si=_JKFAhwT-vvLSFqe
WOUND CARE REPORT
Global Wound Care Market to Reach USD 30.48 Billion by 2030 | MarketsandMarkets(TM)
Advanced wound care technologies, aging populations, and expanding...
All Bases Loaded. Home Run Hitters, Next up to Bat..
Four of the Most Powerful and Well Recognized, US Government Intelligence and Defense Experts, Have Officially Joined Forces With Tiny Sekur Private Data (SWISF) and They Are Next up to Bat.
It doesn't get much...
GeoVax (GOVX) Reports 2025 Year-End Financial Results and Provides Business Update
LIVE QUOTE
Pivotal Phase 3 Trial for GEO-MVA (Mpox/Smallpox Vaccine)
Scheduled to Initiate During the Second Half of This Year
ATLANTA, GA - April 15, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company...
Danger Will Robinson: the NIPAH Virus with a 40-75% Death Rate Lurks.
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Click to Review Report
Subscribe to receive our upcoming 2026 Investors Guide to...
Report: AI Powered Review on GeoVax (GOVX) $1.15
In our view, a research report is designed to gather information on publicly traded companies from press releases, management presentations (including power points), SEC filings, management guidance, industry outlooks, product or service descriptions...
Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).
Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data.
The press release link below list nearly all of John's accolades, but this is more than enough for us....
Three Stocks Percolating, Up 106%, Up 169%, and up 483%.
Odyssey Marine (OMEX) gained 169%, on a259 million share day, from where we added it to 2026 Watch list. Society Pass (SOPA) gained 106%, from its recent low on a 55 million share day....
11 Publicly Traded Companies Cashing in on the AI Cyber Threat Boom
Why the Cybersecurity Sector Is Poised for Explosive Growth Over the Next Five Years
Awareness of the Dangers Is Exploding Upward — and With It, Cybersecurity Budgets
For the first time in history, cybercrime is being...
From $0 to a $1 Billion Valuation in 6 Years, via eSims.
How To Build A Unicorn with Ahmet Bahadir Ozdemir (Airalo) | Antler Global
Fantastic "accidental telecom guy" who turned Sim4Crew which started out as SIM cards for crew members and sailors on ships, into a...
Odyssey Marine (OMEX) Gains 169% on Merger News
American Ocean Minerals Corporation to Merge with Odyssey Marine Exploration, Inc., Creating a $1B U.S.-Controlled Deep-Sea Critical Minerals Platform
March 30th: Adding Odyssey Marine (OMEX) $0.79 and Advanced Gold Exploration $0.36 to Precious Metals Watch...
TMC Pushes US Seafloor Mining Hub.
With 413 million shares outstanding, TMC has lost $2.9 billion in market value in the most recent rout!
Investors have to keep reminding themselves that a pre-feasibility study issued earlier this year assigned a net...
Palantir’s Billionaire CEO, “People With ADHD Will Succeed in the AI Era.”
“There are basically two ways to know you have a future,” the 58-year-old billionaire Alex Karp said on TBPN earlier this month. “One, you have some vocational training. Or two, you’re neurodivergent.” More broadly, neurodivergence can include conditions such...
All Bases Loaded. Home Run Hitters, Next up to Bat..
Four of the Most Powerful and Well Recognized, US Government Intelligence and Defense Experts, Have Officially Joined Forces With Tiny Sekur Private Data (SWISF) and They Are Next up to Bat.
It doesn't get much...
REPORT OpenWorld: The Contrarian’sCase for OPNW
Adding to Watch List. Why VerifyMe's (VRME) $0.90 Reverse Merger Deserves a Second Look. Or First Look for Some.
LIVE QUOTE
RECENT NEWS
VerifyMe Reports Fourth Quarter 2025 Financial Results
Cash of $4.4 million and short-term note receivable...
Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).
Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data.
The press release link below list nearly all of John's accolades, but this is more than enough for us....
11 Publicly Traded Companies Cashing in on the AI Cyber Threat Boom
Why the Cybersecurity Sector Is Poised for Explosive Growth Over the Next Five Years
Awareness of the Dangers Is Exploding Upward — and With It, Cybersecurity Budgets
For the first time in history, cybercrime is being...
The Iran War and AI Cyber Threats
Virtually all cyberattacks will be AI-enabled or entirely AI, says Armadin CEO Kevin Mandia
Kevin Mandia, Armadin CEO, joins ‘Squawk Box’ to discuss the cyber threats facing the U.S. amid the Iran war, impact of...
Cabaletta (CABA) Surges 44% on Massive Volume Spike.
Biotech 12 Pack Off to Nice Start..
Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April!
Biotech Stock Review is...
GeoVax (GOVX) Surges 51% on Massive Volume Spike.
MonkeyPox and Gedeptin Related News Spark New Investor Interest.
MARKET BRIEF
On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...
Paving Past Obstacles on the Path to US Biosecurity
GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China.
National biosecurity has become a frequent topic of conversation in...
GeoVax (GOVX) Reports 2025 Year-End Financial Results and Provides Business Update
LIVE QUOTE
Pivotal Phase 3 Trial for GEO-MVA (Mpox/Smallpox Vaccine)
Scheduled to Initiate During the Second Half of This Year
ATLANTA, GA - April 15, 2026 (NEWMEDIAWIRE)...
Danger Will Robinson: the NIPAH Virus with a 40-75% Death Rate Lurks.
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Click to...
IPOS
StHealth Private Equity Medtech Fund. Alternative Investment BDC.
StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with both yield...
conference calls
GeoVax to Provide Corporate Update on Tuesday May 14, 2024.
Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market cap, addressing...
Latest article
Cabaletta (CABA) Surges 44% on Massive Volume Spike.
Biotech 12 Pack Off to Nice Start..
Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April!
Biotech Stock Review is...
GeoVax (GOVX) Surges 51% on Massive Volume Spike.
MonkeyPox and Gedeptin Related News Spark New Investor Interest.
MARKET BRIEF
On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...
Paving Past Obstacles on the Path to US Biosecurity
GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China.
National biosecurity has become a frequent topic of conversation in...
Most popular
The Blood Sugar Trials.
Can a Swash Buckling Wall Street Analyst Lose Weight and get his Blood Sugar Down From Near 200 to Under 125?
First to be clear,...
Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.
Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003...
Surna Cultivation Technologies Signs Contract for New Addition to Product Portfolio
Converted Air Sanitization Product Partnership to Customer Contract in Under Thirty Days
Louisville, Colorado, April 05, 2022 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) subsidiary, Surna...
Compass Pathways (CMPS) $4.44, Gains 85% Since Adding to Watch List.
Down from $56.95 - But Up from $2.36. Woo hoo!
Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36
We are probably...
LATEST ARTICLES
Latest article
Cabaletta (CABA) Surges 44% on Massive Volume Spike.
Biotech 12 Pack Off to Nice Start..
Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April!
Biotech Stock Review is...
GeoVax (GOVX) Surges 51% on Massive Volume Spike.
MonkeyPox and Gedeptin Related News Spark New Investor Interest.
MARKET BRIEF
On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...
Paving Past Obstacles on the Path to US Biosecurity
GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China.
National biosecurity has become a frequent topic of conversation in...
